Immunogenomic Landscape of Hematological Malignancies
2020 · Cancer Cell · 186 citations
https://doi.org/10.1016/j.ccell.2020.06.002
S
Suvi‐Katri Leivonen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
185
Papers
3.8K
Citations
33
h-index
42
i10-index
Suvi‐Katri Leivonen is an academic researcher from University of Helsinki. The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & Lymphoma Diagnosis and Treatment. The author has an h-index of 33, co-authored 158 publications.
ORCID: 0000-0003-3224-0757Papers by this author
worksHigh‐throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
2013 · Molecular Oncology · 166 citations
https://doi.org/10.1016/j.molonc.2013.10.001
Identification of miR-193b Targets in Breast Cancer Cells and Systems Biological Analysis of Their Functional Impact
2011 · Molecular & Cellular Proteomics · 76 citations
https://doi.org/10.1074/mcp.m110.005322
Hypoxia-activated Smad3-specific Dephosphorylation by PP2A
2009 · Journal of Biological Chemistry · 62 citations
https://doi.org/10.1074/jbc.m109.042978
miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth
2018 · MicroRNA · 40 citations
https://doi.org/10.2174/2211536608666181206124922
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
2017 · Blood Cancer Journal · 35 citations
https://doi.org/10.1038/s41408-017-0033-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat